The future of osteoarthritis therapeutics: emerging biological therapy.
about
Managing osteoarthritisConsequences of metabolic and oxidative modifications of cartilage tissueThe role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.Management of Osteoarthritis with Avocado/Soybean Unsaponifiables.Chondroprotective Effect of Kartogenin on CD44-Mediated Functions in Articular Cartilage and ChondrocytesMeasurement of bone marrow lesions by MR imaging in knee osteoarthritis using quantitative segmentation methods--a reliability and sensitivity to change analysis.Emerging targets in osteoarthritis therapy.Biologic basis of osteoarthritis: state of the evidenceUpdate on biological therapies for knee injuries: osteoarthritis.Viability of Pathologic Cartilage Fragments as a Source for Autologous Chondrocyte Cultures.Adipose, Bone Marrow and Synovial Joint-Derived Mesenchymal Stem Cells for Cartilage Repair.Does intraoperative application of leukocyte-poor platelet-rich plasma during arthroscopy for knee degeneration affect postoperative pain, function and quality of life? A 12-month randomized controlled double-blind trial.The role of metabolism in the pathogenesis of osteoarthritis.Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk.Updates in biological therapies for knee injuries: full thickness cartilage defect.Modulation of Synovial Fluid-Derived Mesenchymal Stem Cells by Intra-Articular and Intraosseous Platelet Rich Plasma AdministrationBiomarkers of (osteo)arthritis.High hopes for cannabinoid agonists in the treatment of rheumatic diseases.Plasma level of Osteopontin does not respond to total replacement Surgery in patients with severe Primary knee/Hip Osteoarthritis.Cytokine-induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment.Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know.
P2860
Q26773279-0A4E579F-8579-489D-A596-C98CAE5BCF7DQ28085716-122E8F02-6C8B-49C4-B58B-38E6B3299A72Q33614316-3D61811E-06DD-41FF-B0D3-A2DC33335524Q33880198-615C116A-FB7E-46BC-A699-609CB286AAC3Q34459643-B1854014-E03C-4419-A235-49E228EBCEC8Q34978183-70A9386F-207F-433B-9B9E-CC0016332DBFQ35191101-A9CD9249-F69D-42B6-90CE-B9356F26BDF8Q35752078-268C35E9-3092-46D9-97F4-03E47052CA85Q35821610-A302810F-F40F-4F91-996F-A5F3E6C5E99CQ36130226-E44640C2-3320-41E0-A35E-2BFD4C47305EQ36700952-A5385233-034B-4AA3-AE57-575D5C7AEAF2Q37516178-24C5EE7E-51F5-45C1-9C28-18FFE46590E8Q38411821-EE12EE61-A7BF-4AF7-A32C-20482D42FEBAQ38734393-DFE4C71D-AC37-4C48-8D50-6AFDC899F000Q38960505-E400F679-E22D-4BD4-A268-10B212FC438AQ41188307-8E17F1DE-A864-4533-B5B5-0780085FA24AQ41581094-25C198E7-BE73-4388-9D8B-7020D0258240Q42869232-C3836869-1533-44F6-9A8F-9723FF451BB1Q43099595-2BF63A3A-448C-48D9-93D8-C4567D856B6FQ51841062-C72E2B43-32FF-4BAE-8F66-D442D3F36830Q52613681-FF111A6D-6F83-434F-9F0F-842AE9A295A2Q55344331-2588D3AD-37BE-4051-B053-6060DC262DA7
P2860
The future of osteoarthritis therapeutics: emerging biological therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The future of osteoarthritis therapeutics: emerging biological therapy.
@en
The future of osteoarthritis therapeutics: emerging biological therapy.
@nl
type
label
The future of osteoarthritis therapeutics: emerging biological therapy.
@en
The future of osteoarthritis therapeutics: emerging biological therapy.
@nl
prefLabel
The future of osteoarthritis therapeutics: emerging biological therapy.
@en
The future of osteoarthritis therapeutics: emerging biological therapy.
@nl
P2860
P1476
The future of osteoarthritis therapeutics: emerging biological therapy.
@en
P2860
P2888
P356
10.1007/S11926-013-0385-4
P577
2013-12-01T00:00:00Z